- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2025 MJH Life Sciences™ , Pharmaceutical Technology - Pharma News and Development Insights. All rights reserved.
Featured Content
European Biotech Targeting Anti-ageing
Oct 2nd 2024
Novel mitophagy inducers and gene therapies that restore cellular function and decelerate the ageing process.
Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?
Mar 4th 2024
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Training for Operational Excellence
Dec 3rd 2023
The bio/pharmaceutical industry is struggling with the challenge of staffing and training.
Billions of Reasons to be Buoyant
Sep 2nd 2023
Pharma's ability to continually reinvent itself will be critical in growing future business operations.
Latest Videos
Latest News
Johnson & Johnson Completes Proteologix Acquisition, Gains Bispecific Antibody Assets
June 28th 2024
Johnson & Johnson gets two bispecific antibodies in early phase development for immune-mediated diseases through its Proteologix acquisition.
Roche and Ascidian Therapeutics Collaborate on Treatments for Neurological Diseases
June 18th 2024
The research collaboration and licensing agreement will focus on the discovery and development of RNA exon editing therapeutics.
Pushing Boundaries to Revolutionize Chronic Inflammation Therapy
June 14th 2024
Novel approaches against chronic inflammation could potentially prevent certain inflammatory diseases and neurological conditions.
Syntegon Acquires Telstar
June 11th 2024
Syntegon will expand its processing and packaging by acquiring the Spanish equipment supplier.
Sterling Invests in Expansion of Integrated ADC Services
May 31st 2024
Sterling is strengthening its development and manufacturing services for ADCs with a dedicated GMP suite at its Wisconsin facility.
Lilly Raises Investment in Indiana Site to $9 Billion to Expand API Manufacturing
May 30th 2024
Lilly’s investment increase is intended to boost manufacturing capacity at its Lebanon, Ind., site for APIs used in the production of tirzepatide and other pipeline drug candidates.
Johnson & Johnson to Acquire Global Rights to Numab Therapeutics’ Bispecific Antibody for Atopic Dermatitis in $1.25 Billion Deal
May 30th 2024
Johnson & Johnson will gain NM26, a bispecific antibody targeting atopic dermatitis, via the acquisition of a wholly owned subsidiary of Numab Therapeutics.
AGC Biologics Partners with BioConnection to Offer Biopharma Drug Substance and Drug Product Development and Manufacturing
May 25th 2024
The partnership aims to provide end-to-end development and manufacturing for biopharmaceutical drug substance and drug product.
Biogen to Acquire HI-Bio in Deal Worth Potentially Up to $1.8 Billion
May 24th 2024
With the acquisition, Biogen gains felzartamab, HI-Bio's lead investigational mAb candidate being developed for the treatment of a range of immune-mediated diseases.
Merck KGaA Announces $600 Million Deal to Acquire Mirus Bio
May 24th 2024
With this acquisition, Merck KGaA will have the capability to offer integrated services for viral vector manufacturing.